Inici › Trastorn depressiu major › Massachusetts › Boston
Assaigs clínics de Trastorn depressiu major a Boston, MA
31 estudis de Trastorn depressiu major busquen participants en centres de Boston i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
ReclutantFase 3
- Adams Clinical Boston, Boston
A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
ReclutantFase 3
- Adams Clinical Boston, Boston
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
ReclutantFase 3
- Boston Childrens Hospital, Boston
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
ReclutantFase 3
- Adams Clinical Boston, Boston
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
ReclutantFase 3
- Vanda Investigational Site, Boston
Accelerated TMS for Perinatal Depression
Reclutant
- Brigham and Women's Hospital, Boston
A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)
ReclutantFase 2
- Seaport Investigator Site, Boston
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)
ReclutantFase 3
- Adams Clinical Boston, Boston
A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
ReclutantFase 2
- Draig Clinical Site, Boston
Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
Reclutant
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
Home-Based tDCS Treatment Of Major Depressive Disorder
Reclutant
- Curavit Clinical Research (virtual study site), Boston
The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder
ReclutantFase 3
- Athinoula A. Martinos Center for Biomedical Imaging, Charlestown · a 1 mi
A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
ReclutantFase 3
- Adams Clinical Boston, Boston
- Adams Clinical Watertown, Boston
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
ReclutantFase 3
- Adams Clinical Boston, Boston
A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder
ReclutantFase 3
- Boston Clinical Trials Llc, Boston
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutantFase 3
- Neurocrine Clinical Site, Boston
Triage Survey for Psychiatry Research Eligibility
ReclutantEstudi observacional
- Adams Clinical, Boston, Boston
Mechanisms Of Orbitofrontal Stimulation in Depression
Reclutant
- Beth Israel Deaconess Medical Center, Boston
Mindfulness-Based fMRI Neurofeedback for Depression
Reclutant
- Northeastern University, Boston
REVEAL Study - Diagnostic Testing for PTSD Using the Senseye Diagnostic Tool
ReclutantFase 3Voluntaris sans benvinguts
- Lindus Health (Virtual Study Site), Boston
Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
ReclutantEstudi observacional
- Beth Israel Deaconess Medical Center, Boston
Transcranial Near Infrared Radiation and Cerebral Blood Flow in Depression - R33
Reclutant
- Harvard Medical School, Boston
Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)
ReclutantFase 2
- Autobahn Site #137, Boston
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression
ReclutantFase 4
- Massachusetts General Hospital, Boston
Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
ReclutantFase 3
- Neurocrine Clinical Site, Boston
Targeting Specific Brain Networks to Treat Specific Symptoms in Depression
ReclutantVoluntaris sans benvinguts
- Massachusetts General Hospital, Boston
Neuroactive Steroid to Treat Depressed Mood: A Trial for People With HIV
ReclutantFase 2
- Massachusetts General Hospital, Boston
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
ReclutantVoluntaris sans benvinguts
- Massachusetts General Hospital, Boston
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
ReclutantFase 2
- Massachusetts General Hospital, Boston
A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
ReclutantFase 4
- Clinical Research Site, Boston
Peripheral Neuroimmune Mechanisms of Hyperthermia
Reclutant
- Massachusetts General Hospital Depression Clinical & Research Program, Boston
Assaigs de Trastorn depressiu major en altres ciutats
- New York City, NY37 estudis
- Atlanta, GA25 estudis
- Philadelphia, PA23 estudis
- Orlando, FL19 estudis
- Miami, FL18 estudis
- Tampa, FL17 estudis
- Chicago, IL17 estudis
- Houston, TX16 estudis
- San Diego, CA16 estudis
- Little Rock, AR14 estudis
- Orange, CA13 estudis
- Austin, TX13 estudis
Altres estudis a Boston
- Càncer de mama111 estudis
- Càncer de pulmó de cèl·lules no petites90 estudis
- Càncer (tots els tipus)86 estudis
- Càncer colorrectal63 estudis
- Càncer metastàtic63 estudis
- Càncer de pulmó62 estudis
- Càncer d'ovari61 estudis
- Càncer de pròstata59 estudis
- Depressió52 estudis
- Càncer d'endometri50 estudis
- Insuficiència cardíaca44 estudis
- Leucèmia mieloide aguda44 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.